Catalyst Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CPRX Nasdaq 2836 catalystpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Catalyst Pharmaceuticals, Inc.

GlobeFlex Exits NCR Atleos After Brink’s Buyout Deal - May 20th, 2026 3:54 pm
Angelini Buyout And FIRDAPSE Settlement Reframe Catalyst Pharmaceuticals Story - May 20th, 2026 2:08 pm
CPRX or UTHR: Which Is the Better Value Stock Right Now? - May 14th, 2026 9:40 am
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - May 12th, 2026 9:18 am
Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - May 11th, 2026 4:30 pm
Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates - May 11th, 2026 4:05 pm
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results - May 11th, 2026 2:12 pm
Angelini Pharma agrees $4.1bn Catalyst Pharmaceuticals acquisition - May 11th, 2026 3:27 am
Catalyst Pharmaceuticals Buyout And FIRDAPSE Patents Reframe Investor Outlook - May 10th, 2026 1:10 am
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth - May 9th, 2026 10:13 am
Angelini Pharma acquires Catalyst Pharmaceuticals for $4.1 billion - May 8th, 2026 7:28 am
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn - May 8th, 2026 4:06 am
Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast - May 7th, 2026 2:02 pm
Sector Update: Health Care Stocks Softer Late Afternoon - May 7th, 2026 1:44 pm
UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook - May 7th, 2026 10:00 am
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth - May 7th, 2026 9:42 am
Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up - May 7th, 2026 9:35 am
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - May 7th, 2026 9:30 am
Seeking Clues to Catalyst (CPRX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics - May 7th, 2026 7:15 am
Angelini to buy Catalyst in $4B play for rare neuro drugs - May 7th, 2026 5:20 am